NEW YORK - March 13, 2026 - GROWNSY, the brand dedicated to supporting new parents with cutting-edge and thoughtfully ...
LOS ANGELES (KABC) -- One in eight U.S. adults struggle to breathe and battle the persistent pain and discomfort of chronic sinusitis. Even with sprays, irrigations and pills, a staggering 80% of ...
Credit: Milestone Pharmaceuticals. Each nasal spray device delivers 2 sprays containing a total of etripamil 70mg. The intranasal therapy consists of a novel calcium channel blocker and is designed to ...
ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer EURneffy-t ...
Early research suggests a new nasal spray vaccine could protect against multiple respiratory threats.
Nove Device creates discreet, everyday-carry kits to hold emergency naloxone nasal sprays, empowering users to respond quickly and without stigma. The company builds its naloxone nasal spray carry ...
Expands institutional footprint with potential penetration of more than ~ 60% of the U.S. market, while expanding reach across EMS providers and ...
LTR Pharma recently announced the dosing of the first patients in the Phase II study of SPONTAN ®, which is evaluating the ...
The global nasal drug delivery technology market is projected to grow at a CAGR of approximately 7% over the next five years.
ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results